Zoetis inc stock.

On February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc. (the "Company"), for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company. Mr.View Zoetis Inc ZTS investment & stock information. Get the latest Zoetis Inc ZTS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.The estimated Net Worth of Gregory Norden is at least $9.76 Millón dollars as of 17 June 2023. Mr. Norden owns over 14,851 units of Zoetis Inc stock worth over $8,039,417 and over the last 11 years he sold ZTS stock worth over $1,360,615. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Ms Mamilli ZTS stock SEC Form 4 insiders trading. Ms has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 5,817 units of ZTS stock worth $943,692 on 11 February 2023.. The largest trade she's ever made was exercising 5,817 units of Zoetis Inc stock on 11 …Nov 8, 2023 · ZTS’s Market Performance. Zoetis Inc (ZTS) has seen a 6.47% rise in stock performance for the week, with a -4.26% decline in the past month and a -11.72% plunge in the past quarter. The volatility ratio for the week is 3.92%, and the volatility levels for the past 30 days are at 2.42% for ZTS.

Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022.

Zoetis Inc. (ZTS) Outperforms Peers and Shows Promising Growth: A Strong Buy Recommendation November 3, 2023TipRanks. Zoetis price target lowered to $255 from $260 at Barclays November 3 ...

Back to ZTS Overview. The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides ...Webull offers Zoetis Inc stock information, including NYSE: ZTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZTS stock news, and many more online research tools to help you make informed decisions.Welcome to Zoetis. As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. test.Back to ZTS Overview. The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides ...

Pfizer owns 400,985,000 shares of Zoetis Class B common stock, which represents approximately 80.2% of the outstanding common stock of Zoetis. Prior to completion of the exchange offer, Pfizer intends to convert its Zoetis Class B common stock into Zoetis Class A common stock in an amount sufficient such that Zoetis Class A …

The Zoetis stock price fell by -0.667% on the last day (Wednesday, 29th Nov 2023) from $176.97 to $175.79. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.61% from a day low at $175.24 to a day high of $178.06. The price has risen in 6 of the last 10 days and is up by 1.82% over the past 2 weeks.

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers ...Feb 8, 2023 · Zoetis Declares Second Quarter 2023 Dividend. February 8, 2023. PARSIPPANY, N.J.-- (BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the second quarter of 2023. The dividend will be paid on Thursday, June 1, 2023, to all holders of record of the Company’s common stock as of the ... Michael has made over 37 trades of the Zoetis Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 1,626 units of ZTS stock worth $287,623 on 11 February 2023.Zoetis. Market Cap. Today's Change. (0.91%) $1.61. Current Price. $178.28. Price as of December 1, 2023, 12:05 p.m. ET. You’re reading a free article with opinions that may differ from The ...Get a real-time Zoetis Inc. (ZTS) stock price quote with breaking news, financials, statistics, charts and more.The estimated Net Worth of William C Jr Steere is at least $6.34 millió dollars as of 20 May 2021. Mr. Steere owns over 16,170 units of Zoetis Inc stock worth over $6,013,788 and over the last 20 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc.

Zoetis Quarterly Corporate Performance - Second Quarter 2023. August 8, 2023 08:30 AM ET. Webcast. Presentation.The Dividend Yield % of Zoetis Inc (ZTS) is 0.84% (As of Today), Highest Dividend Payout Ratio of Zoetis Inc (ZTS) was 0.3. The lowest was 0.16. And the median was 0.19. The Forward Dividend Yield % of Zoetis Inc (ZTS) is 0.84%. For more information regarding to dividend, please check our Dividend Page . The estimated Net Worth of Paul Bisaro is at least $38.1 millió dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.“With Zoetis’ global sales and regulatory expertise in more than 45 markets, we look forward to expanding the impact and reach of the entire Jurox portfolio.” Jurox develops and manufactures more than 150 products in areas such as parasiticides, anti-infectives, anaesthesia, cardiology and reproduction for animals. About ZoetisDec 1, 2023 · Grading Zoetis Inc Stock. Before you choose to buy, sell or hold Zoetis Inc stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement. April 30, 2020. Launched by leading animal health company Zoetis. Uniquely combines preventive care with best-in-class health insurance for dogs and cats. NEW YORK-- ( BUSINESS WIRE )-- Pumpkin Insurance Services , Inc. (“Pumpkin”), a new pet insurance agency and pet care company, announced today the launch of its new insurance and optional ...

The estimated Net Worth of Paul Bisaro is at least $37.2 Million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $12,782,997 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.

Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology.Home → Join Us. Zoetis means something different to every one of our colleagues. But the one thing that unites us is our purpose. Our purpose is to nurture the world and humankind by advancing care for animals. And every colleague in every role from the lab, manufacturing site, in field or clinics with our customers, or the office impacts that every …Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022.Stock buybacks reduce the number of shares outstanding, so the remaining shareholders receive. ... Zoetis Inc. (ZTS) Shareholder Yield . 2.5%. Forward 5-Year Annual EPS Estimate +15.6%.Dec 1, 2023 · A high-level overview of Zoetis Inc. (ZTS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Nov 8, 2023 · ZTS’s Market Performance. Zoetis Inc (ZTS) has seen a 6.47% rise in stock performance for the week, with a -4.26% decline in the past month and a -11.72% plunge in the past quarter. The volatility ratio for the week is 3.92%, and the volatility levels for the past 30 days are at 2.42% for ZTS. ZTS Análisis Financiero de Acciones - Zoetis Inc - Class A (NYSE) Stock.Zoetis Inc. (4ZTS.BIT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis Inc. | Borsa Italiana: 4ZTS | Borsa Italiana

Welcome to Zoetis. As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries.

Zoetis Declares Fourth Quarter 2023 Dividend. PARSIPPANY, N.J., October 12, 2023--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth ...

Hayward Pool Products Inc. is a leading manufacturer and distributor of swimming pool equipment and supplies. With over 80 years of experience, the company has been at the forefront of innovation in the swimming pool industry.175.79 Volume 14 Change -1.18 % Change -0.67% Today's Open 177.87 Previous Close 176.97 Intraday High 178.06 Intraday Low 175.24 52 Week High 194.99 …Zoetis Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ZTS stock price.In the previous week, Boston Scientific had 6 more articles in the media than Zoetis. MarketBeat recorded 12 mentions for Boston Scientific and 6 mentions for Zoetis. Boston Scientific's average media sentiment score of 1.32 beat Zoetis' score of 0.64 indicating that Zoetis is being referred to more favorably in the news media.18 feb 2022 ... ... Zoetis Inc. Zoetis (ZTS) stock forecast: will the healthcare stock rebound? – Photo: Shutterstock. US-based animal healthcare company Zoetis ...Zoetis Inc. (ZTS Quick Quote ZTS - Free Report) reported first-quarter 2023 adjusted earnings (excluding one-time items) of $1.31 per share, which beat the Zacks Consensus Estimate and our model ...Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ...Zoetis Inc. (ZTS) Stock Price, Quote, News & Analysis Black Friday is here! Save 45% on Premium AND Alpha Picks now » ZTS Zoetis Inc. Stock Price & Overview 32.49K followers $180.21...Sep 30, 2022 · PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals. Zoetis' $2 billion acquisition of Abaxis in 2018 was the company's most substantial acquisition, and it also marked the company's entrance into the veterinary diagnostics market. Abaxis provides ...Zoetis Inc (ZTS) stock is up 1.56% while the S&P 500 is lower by -0.73% as of 3:06 PM on Monday, Dec 4. ZTS is up $2.79 from the previous closing price of $179.13 on volume of 907,604 shares. Over the past year the S&P 500 is up 14.06% while ZTS is up 17.12%. ZTS earned $4.92 a per share in the over the last 12 months, giving it a price-to ...Willie Reed ZTS stock SEC Form 4 insiders trading. Willie has made over 9 trades of the Zoetis Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 1,626 units of ZTS stock worth $280,729 on 11 February 2023.. The largest trade he's ever made was exercising 3,704 units of Zoetis Inc stock on 14 …

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...Instagram:https://instagram. baicxmargin trading calculatorafter hours stock newsdall e 3 free Zoetis Quarterly Corporate Performance - Second Quarter 2023. August 8, 2023 08:30 AM ET. Webcast. Presentation.Jul 11, 2023 · Information News Events & Presentations Stock Information Financials Governance Contact Zoetis.com Stock Quote Price 175.79 Volume 14 Change -1.18 % Change -0.67% Today's Open 177.87 Previous Close 176.97 Intraday High 178.06 Intraday Low 175.24 52 Week High 194.99 52 Week Low 140.76 Pricing delayed by 20 minutes. Last Updated 11/29/2023 4:00 PM fabalellablue jet stock Welcome to Zoetis. As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. test. brandless luggage Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ...Zoetis Inc. (NYSE:ZTS) today announced that its Board of Directors has authorized a $1.5 billion multi-year share repurchase program as part of its long-term capital allocation plans. The shares are expected to be repurchased at the discretion of management over a multi-year period, and the program can be cancelled at any time.